Valeant sets sights on Mideast, North Africa with Amoun purchase

Valeant Pharmaceuticals International, Inc. says it will buy a major Egyptian pharmaceutical company for about $800 million US as a platform for further expansion in the Middle East and North Africa.

from CBC | Health News http://ift.tt/1CLhEhj